Review of MRI in the emergency department compared rates of MS as differential diagnosis and final diagnosis.
Magnetic resonance images from the emergency department (ED) can lead to early guidance for a diagnosis of a demyelinating disorder, according to study published in the American Journal of Roentgenology.
Researchers from The Johns Hopkins Medical Institutions in Baltimore, MD, performed a retrospective study to examine the potential value of the radiologists' MR imaging reports for patients with previously undiagnosed multiple sclerosis (MS) who presented to the ED.
The researchers reviewed electronic medical records of 61 women and 31 men (mean age of 41.2) who underwent imaging with their institution’s ED MRI scanner, and for whom the radiologist reported a possible demyelinating disorder.
The results showed for 48 of the 92 patients (52.2%), the radiology report suggested a demyelinating diagnosis and the patient was given this diagnosis as the final outcome. Where a demyelinating disorder was placed as the only, first, second, or third (or later) differential diagnosis, the final diagnosis was concordant with demyelination in 43 of 51 patients (84.3%), three of eight patients (37.5%), two of 11 patients (18.2%), and zero of 22 patients (0%), respectively.
The researchers concluded that radiologist-suggested demyelinating disease as the top differential diagnosis after MRI showed a high concordance rate with demyelinating disease as the final diagnosis. Having such findings from scans in the ED for neurologic deficits can lead to early guidance for a diagnosis of demyelination to be made, resulting in downstream effects, such as reduced admission rates, avoidance of unnecessary use of other procedures, and early commencement of disease-modifying therapy.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.